- Home
- ALVR vs STRW Comparison
ALVR vs STRW Comparison
Compare ALVR & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- STRW
- Stock Information
- Founded
- ALVR 2013
- STRW 2015
- Country
- ALVR United States
- STRW United States
- Employees
- ALVR N/A
- STRW N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- STRW Real Estate Investment Trusts
- Sector
- ALVR Health Care
- STRW Real Estate
- Exchange
- ALVR Nasdaq
- STRW Nasdaq
- Market Cap
- ALVR 87.7M
- STRW 79.7M
- IPO Year
- ALVR 2020
- STRW N/A
- Fundamental
- Price
- ALVR $0.94
- STRW $12.52
- Analyst Decision
- ALVR Sell
- STRW Strong Buy
- Analyst Count
- ALVR 5
- STRW 1
- Target Price
- ALVR $1.00
- STRW $10.00
- AVG Volume (30 Days)
- ALVR 155.6K
- STRW 14.4K
- Earning Date
- ALVR 11-04-2024
- STRW 11-11-2024
- Dividend Yield
- ALVR N/A
- STRW 4.11%
- EPS Growth
- ALVR N/A
- STRW N/A
- EPS
- ALVR N/A
- STRW 0.47
- Revenue
- ALVR N/A
- STRW $108,357,000.00
- Revenue This Year
- ALVR N/A
- STRW N/A
- Revenue Next Year
- ALVR N/A
- STRW N/A
- P/E Ratio
- ALVR N/A
- STRW $27.19
- Revenue Growth
- ALVR N/A
- STRW 12.45
- 52 Week Low
- ALVR $0.58
- STRW $6.56
- 52 Week High
- ALVR $2.49
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- STRW 62.39
- Support Level
- ALVR $0.74
- STRW $11.57
- Resistance Level
- ALVR $0.91
- STRW $12.36
- Average True Range (ATR)
- ALVR 0.06
- STRW 0.32
- MACD
- ALVR 0.01
- STRW 0.05
- Stochastic Oscillator
- ALVR 94.50
- STRW 93.10
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.